HomeCompareFLDM vs DGRO

FLDM vs DGRO: Dividend Comparison 2026

FLDM yields 53.91% · DGRO yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FLDM wins by $449.4K in total portfolio value
10 years
FLDM
FLDM
● Live price
53.91%
Share price
$3.71
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$481.1K
Annual income
$103,477.45
Full FLDM calculator →
DGRO
iShares Core Dividend Growth ETF
● Live price
2.13%
Share price
$68.98
Annual div
$1.47
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$31.6K
Annual income
$239.96
Full DGRO calculator →

Portfolio growth — FLDM vs DGRO

📍 FLDM pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFLDMDGRO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FLDM + DGRO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FLDM pays
DGRO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FLDM
Annual income on $10K today (after 15% tax)
$4,582.21/yr
After 10yr DRIP, annual income (after tax)
$87,955.83/yr
DGRO
Annual income on $10K today (after 15% tax)
$181.24/yr
After 10yr DRIP, annual income (after tax)
$203.97/yr
At 15% tax rate, FLDM beats the other by $87,751.87/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FLDM + DGRO for your $10,000?

FLDM: 50%DGRO: 50%
100% DGRO50/50100% FLDM
Portfolio after 10yr
$256.3K
Annual income
$51,858.70/yr
Blended yield
20.23%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on FLDM right now

FLDM
Analyst Ratings
8
Buy
2
Hold
Consensus: Buy
Altman Z
1.4
Piotroski
2/9
DGRO
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FLDM buys
0
DGRO buys
0
No recent congressional trades found for FLDM or DGRO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFLDMDGRO
Forward yield53.91%2.13%
Annual dividend / share$2.00$1.47
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$481.1K$31.6K
Annual income after 10y$103,477.45$239.96
Total dividends collected$390.4K$2.3K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: FLDM vs DGRO ($10,000, DRIP)

YearFLDM PortfolioFLDM Income/yrDGRO PortfolioDGRO Income/yrGap
1← crossover$16,091$5,390.84$11,293$213.22+$4.8KFLDM
2$25,324$8,106.83$12,730$217.32+$12.6KFLDM
3$39,021$11,923.98$14,326$221.10+$24.7KFLDM
4$58,923$17,171.16$16,098$224.56+$42.8KFLDM
5$87,281$24,233.04$18,064$227.74+$69.2KFLDM
6$126,938$33,547.23$20,246$230.65+$106.7KFLDM
7$181,421$45,597.87$22,666$233.30+$158.8KFLDM
8$255,027$60,905.73$25,349$235.73+$229.7KFLDM
9$352,893$80,014.99$28,325$237.94+$324.6KFLDM
10$481,073$103,477.45$31,624$239.96+$449.4KFLDM

FLDM vs DGRO: Complete Analysis 2026

FLDMStock

Fluidigm Corporation creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar reagents, Maxpar direct immune profiling assays, Maxpar on demand reagents, and IMC panel kits for immuno-oncology. The company also provides preparatory instruments, such as Juno systems; and analytical instruments comprising Biomark HD system and EP1 system. In addition, it offers integrated fluidic circuits (IFCs), such as library preparation IFCs, Juno genotyping IFC, dynamic array IFCs, digital array IFCs, and Flex Six IFC; and assays and reagents, including Advanta RNA-Seq NGS library prep kits, Advanta Dx SARS-CoV-2 RT-PCR assays, Advanta Dx COVID-19 EASE assays, delta gene and SNP type assays, access array target-specific primers and targeted sequencing prep primers, and targeted DNA Seq library assays. Further, the company offers single cell microfluidics that comprise C1 systems; preparatory analytical instruments, which include C1 IFCs; and software solutions. It sells its products to academic research institutions; translational research and medicine centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology, and plant and animal research companies; and contract research organizations. Fluidigm Corporation has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Mycometrix Corporation and changed its name to Fluidigm Corporation in April 2001. Fluidigm Corporation was incorporated in 1999 and is headquartered in South San Francisco, California.

Full FLDM Calculator →

DGROETF

The iShares Core Dividend Growth ETF seeks to track the investment results of an index composed of U.S. equities with a history of consistently growing dividends.

Full DGRO Calculator →
📬

Get this FLDM vs DGRO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FLDM vs SCHDFLDM vs JEPIFLDM vs OFLDM vs KOFLDM vs MAINFLDM vs VIGFLDM vs NOBLFLDM vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.